Authors’ Reply to Alatorre et al.: “Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison”

Detalles Bibliográficos
Autores principales: Erder, M. Haim, Xie, Jipan, Signorovitch, James E., Chen, Kristina S., Hodgkins, Paul, Lu, Mei, Wu, Eric Q., Sikirica, Vanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663979/
https://www.ncbi.nlm.nih.gov/pubmed/23592392
http://dx.doi.org/10.1007/s40258-013-0025-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663979/
https://www.ncbi.nlm.nih.gov/pubmed/23592392
http://dx.doi.org/10.1007/s40258-013-0025-1

Ejemplares similares